Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Low Back Pain

NCT00313014 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
660
Enrollment
INDUSTRY
Sponsor class

Stopped Terminated early due to administrative reasons unrelated to efficacy or safety.

Conditions

Interventions

Sponsor

Purdue Pharma LP